Cargando…

Melanoma-Derived Extracellular Vesicles Bear the Potential for the Induction of Antigen-Specific Tolerance

Background: Cancer-induced immunosuppression is antigen-specific rather than systemic and the mechanisms for the antigen specificity are incompletely understood. Here we explore the option that tumor-associated antigens (TAAs) may be transferred to antigen-presenting cells (APCs), together with immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Düchler, Markus, Czernek, Liliana, Peczek, Lukasz, Cypryk, Wojciech, Sztiller-Sikorska, Malgorzata, Czyz, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679195/ https://www.ncbi.nlm.nih.gov/pubmed/31269655 http://dx.doi.org/10.3390/cells8070665

Ejemplares similares

Small Extracellular Vesicles Loaded with Immunosuppressive miRNAs Leads to an Inhibition of Dendritic Cell Maturation
por: Czernek, Liliana, et al.
Publicado: (2022)

Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression
por: Czernek, Liliana, et al.
Publicado: (2017)

Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres
por: Czyz, Malgorzata, et al.
Publicado: (2013)

Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2020)

Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2014)

Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
por: Hartman, Mariusz L., et al.
Publicado: (2020)

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations
por: Hartman, Mariusz L., et al.
Publicado: (2016)

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program
por: Czyz, Malgorzata, et al.
Publicado: (2019)

17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF(V600E) inhibitors in melanoma cells of different genetic subtypes
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Exosomes as Messengers between Mother and Fetus in Pregnancy
por: Czernek, Liliana, et al.
Publicado: (2020)

Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of (V600E)BRAF melanoma cells and their response to vemurafenib and trametinib in vitro
por: Zalesna, Izabela, et al.
Publicado: (2017)

Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy
por: Kluszczynska, Katarzyna, et al.
Publicado: (2023)

CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles
por: Horodecka, Katarzyna, et al.
Publicado: (2021)

Melanoma-Derived Extracellular Vesicles: Focus on Their Proteome
por: Surman, Magdalena, et al.
Publicado: (2019)

From Inflammasome to Exosome—Does Extracellular Vesicle Secretion Constitute an Inflammasome-Dependent Immune Response?
por: Cypryk, Wojciech, et al.
Publicado: (2018)

HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018)

WNT Signaling in Melanoma
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2020)

Role of miRNAs in Melanoma Metastasis
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2019)

The Functional Role of Long Non-Coding RNAs in Melanoma
por: Wozniak, Michal, et al.
Publicado: (2021)

MITF in melanoma: mechanisms behind its expression and activity
por: Hartman, Mariusz L., et al.
Publicado: (2014)

The Roles of Extracellular Vesicles in Malignant Melanoma
por: Cheng, Ying-Chen, et al.
Publicado: (2021)

The Role of Extracellular Vesicles in Melanoma Progression
por: Lattmann, Evelyn, et al.
Publicado: (2022)

Editorial: The functions of extracellular vesicles in melanoma
por: García-Silva, Susana, et al.
Publicado: (2023)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
por: Osrodek, Marta, et al.
Publicado: (2020)

Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
por: Horrevorts, Sophie K., et al.
Publicado: (2019)

Physiologically Relevant Oxygen Concentration (6% O(2)) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro
por: Osrodek, Marta, et al.
Publicado: (2019)

Deciphering the Functional Role of RIPK4 in Melanoma
por: Madej, Ewelina, et al.
Publicado: (2021)

“Liquid biopsy” - extracellular vesicles as potential novel players towards precision medicine in asthma
por: Ambrożej, Dominika, et al.
Publicado: (2022)

Immunosuppressive Extracellular Vesicles as a Linking Factor in the Development of Tumor and Endometriotic Lesions in the Gynecologic Tract
por: Soroczynska, Karolina, et al.
Publicado: (2022)

Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
por: Mannavola, Francesco, et al.
Publicado: (2019)

Mechanisms of extracellular vesicle-mediated immune evasion in melanoma
por: Dieterich, Lothar C.
Publicado: (2022)

In Vitro Interaction of Melanoma-Derived Extracellular Vesicles with Collagen
por: Palmulli, Roberta, et al.
Publicado: (2023)

TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF(V600E) melanoma cells
por: Hartman, Mariusz L., et al.
Publicado: (2019)

MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression
por: Wróblewska, Joanna Patrycja, et al.
Publicado: (2022)

Induction of tolerance to autoimmune diabetes with islet antigens
Publicado: (1992)

Antigen compartmentation and T helper cell tolerance induction
Publicado: (1996)

Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance
por: Kishimoto, Takashi Kei, et al.
Publicado: (2018)

The Methods of Choice for Extracellular Vesicles (EVs) Characterization
por: Szatanek, Rafał, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uesjfj36jc4pb9dgse1r7fqrhb